Bristol Myers Squibb Co (CELG-RI) SEC Filings — 2025
15 SEC filings for Bristol Myers Squibb Co (CELG-RI) in 2025.
Filings
- Bristol Myers Squibb Issues Over $20 Billion in New Notes — 8-K · Nov 18, 2025
- Bristol Myers Squibb Files 8-K — 8-K · Nov 10, 2025
- Bristol Myers Squibb Co 8-K Filing — 8-K · Nov 3, 2025
- BMS Earnings Soar 82% on Growth Portfolio, Legacy Drugs Decline — 10-Q · Oct 30, 2025
- BMS Q2 Revenue Dips Amid Rising R&D Spend — 10-Q · Jul 31, 2025
- Bristol Myers Squibb Reports Officer Changes & Financials — 8-K · Jul 25, 2025
- Bristol Myers Squibb Reports on Shareholder Votes — 8-K · May 7, 2025
- Bristol Myers Squibb Q1 2025 Update — 10-Q · Apr 24, 2025
- Bristol Myers Squibb Files Proxy Materials — DEFA14A · Apr 15, 2025
- Bristol Myers Squibb Files Proxy Materials — DEFA14A · Mar 26, 2025
- Bristol Myers Squibb Executive Compensation Revealed — DEF 14A · Mar 26, 2025
- Bristol Myers Squibb Appoints New Chief Medical Officer — 8-K · Feb 18, 2025
- Bristol Myers Squibb Files 2024 Annual Report — 10-K · Feb 12, 2025
- Bristol Myers Squibb Files 8-K on Financials — 8-K · Feb 6, 2025
- Bristol Myers Squibb Files 8-K on Financial and Corporate Matters — 8-K · Jan 13, 2025